Abstract
Solid organ transplant recipients depend on multiple immunosuppressive drugs, given in combination, to prevent rejection of their allografts. These patients often require many other therapeutic agents to treat underlying illnesses or concurrent diseases. Whenever a new medication is administered to a transplant patient, the potential exists for increasing or decreasing the tissue concentrations of immunosuppressive agents. This can lead to serious complications, such as over-immunosuppression and infection, under-immunosuppression and acute rejection, or additive toxicities, including nephrotoxicity. New immunosuppressants are under development and in clinical use, such as FK506, deoxyspergualin, OG 37-325, rapamycin, brequinar, and mycophenolate mofetil, thereby creating the possibility of many new drug-drug interactions.
Citations
Aug 15, 2002·Transplantation Proceedings·N M SifontisE M Vasquez
Jun 18, 1999·Gastroenterology Clinics of North America·R B Stein, S B Hanauer
Jul 25, 2003·Lancet Neurology·Philip N Patsalos, Emilio Perucca
Mar 30, 2006·Transplantation·Wei TangJian-ping Zuo
Aug 1, 1997·Seminars in Veterinary Medicine and Surgery (small Animal)·E Miller
Oct 27, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Dec 17, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·Marco SenzoloBurra Patrizia
May 23, 2006·Journal of Neuroimmunology·Yun-Feng FuJian-Ping Zuo
Jan 10, 2017·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Minkey Wungwattana, Marizela Savic
Aug 31, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Madhura PradhanKathy L Jabs
May 31, 2001·British Journal of Haematology·C LiatsosA K Burroughs
Dec 1, 2004·Transplant Infectious Disease : an Official Journal of the Transplantation Society·K A MarrC Sable
Apr 21, 1998·Annals of Clinical Biochemistry·A K Trull
Apr 4, 1998·Antimicrobial Agents and Chemotherapy·J NeytsE De Clercq
Feb 17, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A M de MattosW M Bennett